Answers are grounded in this paper and cite their sources.
OBJECTIVE: This study examined the global burden of early-onset nasopharyngeal carcinoma (NPC). STUDY DESIGN: Data on early-onset NPC patients aged 15 to 49 years from 1990 to 2021 were from GBD 2021 to evaluate disease burden and forecast to 2050. SETTING: Early-onset NPC patients aged 15 to 49 years; Global Burden of Disease (GBD) database 2021; period 1990 to 2021. METHODS: The burden of NPC was evaluated using incidence, mortality, disability-adjusted life-years (DALYs), sociodemographic index (SDI), and average annual percentage change (AAPC). Changes in risk factors affecting NPC were also analyzed. Bayesian age-period-cohort analysis was applied to forecast the disease burden spanning 2022 to 2050. RESULTS: Globally, the incidence, mortality, and DALYs of early-onset NPC all declined during 1990 to 2021. The AAPC of incidence, mortality, and DALYs were -0.32 (95% CI: -0.39 to -0.26), -2.12 (-2.16 to -2.08), and -2.09 (-2.13 to -2.05), respectively. The DALYs for NPC exhibited a markedly declining trend among various SDI regions over the 1990-2021 period. East Asia [AAPC: -3.19 (-3.26 to -3.12)] and Western Europe [AAPC: -3.04 (-3.16 to -2.96)] experienced the largest drops in DALYs from 1990 to 2021. High alcohol consumption, smoking, and formaldehyde exposure were major contributing factors to DALYs for early-onset NPC, with no significant changes observed between 1990 and 2021. From 2022 to 2050, the disease burden of early-onset NPC worldwide is projected to decline. CONCLUSIONS: Globally, the burden of early-onset NPC declined during 1990 to 2021 period and is projected to continue to decline in the future.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: